Type 2 diabetes drug also produces better renal outcomes
A drug that lowers blood sugar levels for people with type 2 diabetes produces better renal outcomes, according to new research by The George Institute for Global Health.
“The positive trial results bode well for the Type 2 diabetes community, in which nearly one-third of all patients suffer from diabetic kidney disease,” said Vlado Perkovic, Executive Director, The George Institute for Global Health, Australia.
The findings were presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting. Read more.